Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube and primary peritoneal cancer: a change in surgical approach

Author：  

Publisher： Informa Healthcare

ISSN： 1473-3404

Source： The Women's Oncology Review, Vol.4, Iss.4, 2004-12, pp. : 263-264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Survival Impact of Surgical Cytoreduction in Stage IV Epithelial Ovarian Cancer

By Bristow R.E.   Montz F.J.   Lagasse L.D.   Leuchter R.S.   Karlan B.Y.  

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 278-287

Elsevier

Access to resources Recommend Favorite

Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma

By Campos Susana  

The Women's Oncology Review, Vol. 5, Iss. 2, 2005-06 ,pp. : 105-107

Informa Healthcare

Access to resources Recommend Favorite

Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer

By Miller Brigitte  

The Women's Oncology Review, Vol. 5, Iss. 3, 2005-09 ,pp. : 159-160

Informa Healthcare

Access to resources Recommend Favorite

Clinical Outcome of Tertiary Surgical Cytoreduction in Patients with Recurrent Epithelial Ovarian Cancer

By Fotopoulou Christina  

Annals of Surgical Oncology, Vol. 18, Iss. 1, 2011-01 ,pp. : 49-57

Springer Publishing Company

Access to resources Recommend Favorite

Pegylated liposomal doxorubicin for platinum-resistant or refractory Müllerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of Fallopian tube and peritoneal carcinoma): A single-institutional experience

By                    

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 35-38

Spandidos Publications

Access to resources Recommend Favorite